Retatrutide 30mg
$360.00
In stock
A triple receptor agonist peptide targeting GLP-1, GIP and glucagon receptor pathways. Associated in research discussions with metabolic regulation and body composition endpoints. The 30mg presentation provides a higher total quantity per vial.